The realm of medical research is constantly evolving, and at the forefront of this revolution stands advanced peptide synthesis. These tiny protein fragments hold immense promise for revolutionizing healthcare. Researchers are exploiting the power of synthetic peptides to develop novel therapeuti

Viking Therapeutics has formed a mutually beneficial alliance with U.S. biopharmaceutical companies to develop and manufacture its GLP-1 drug candidate, VK2735. This marks a significant advancement in securing dependable production capabilities for these vital therapeutic agents. The agreement en